Literature DB >> 9707212

Normoxic ventilation after cardiac arrest reduces oxidation of brain lipids and improves neurological outcome.

Y Liu1, R E Rosenthal, Y Haywood, M Miljkovic-Lolic, J Y Vanderhoek, G Fiskum.   

Abstract

BACKGROUND AND
PURPOSE: Increasing evidence that oxidative stress contributes to delayed neuronal death after global cerebral ischemia has led to reconsideration of the prolonged use of 100% ventilatory O2 following resuscitation from cardiac arrest. This study determined the temporal course of oxidation of brain fatty acyl groups in a clinically relevant canine model of cardiac arrest and resuscitation and tested the hypothesis that postischemic ventilation with 21% inspired O2, rather than 100% O2, results in reduced levels of oxidized brain lipids and decreased neurological impairment.
METHODS: Neurological deficit scoring and high performance liquid chromatography measurement of fatty acyl lipid oxidation were used in an established canine model using 10 minutes of cardiac arrest followed by resuscitation with different ventilatory oxygenation protocols and restoration of spontaneous circulation for 30 minutes to 24 hours.
RESULTS: Significant increases in frontal cortex lipid oxidation occurred after 10 minutes of cardiac arrest alone with no reperfusion and after reperfusion for 30 minutes, 2 hours, and 24 hours (relative total 235-nm absorbing peak areas=7.1+/-0.7 SE, 17.3+/-2.7, 14.2+/-3.2, 16.1+/-1.0, and 14.0+/-0.8, respectively; n=4, P<0.05). The predominant oxidized lipids were identified by gas chromatography/mass spectrometry as 13- and 9-hydroxyoctadecadienoic acids (13- and 9-HODE). Animals ventilated on 21% to 30% O2 versus 100% O2 for the first hour after resuscitation exhibited significantly lower levels of total and specific oxidized lipids in the frontal cortex (1.7+/-0.1 versus 3.12+/-0.78 microg 13-HODE/g wet wt cortex., n=4 to 6, P<0.05) and lower neurological deficit scores (45.1+/-3.6 versus 58.3+/-3.8, n=9, P<0.05).
CONCLUSIONS: With a clinically relevant canine model of 10 minutes of cardiac arrest, resuscitation with 21% versus 100% inspired O2 resulted in lower levels of oxidized brain lipids and improved neurological outcome measured after 24 hours of reperfusion. This study casts further doubt on the appropriateness of present guidelines that recommend the indiscriminate use of 100% ventilatory O2 for undefined periods during and after resuscitation from cardiac arrest.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707212     DOI: 10.1161/01.str.29.8.1679

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  54 in total

1.  Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Circulation       Date:  2010-10-19       Impact factor: 29.690

2.  Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

Authors:  Monica E Kleinman; Allan R de Caen; Leon Chameides; Dianne L Atkins; Robert A Berg; Marc D Berg; Farhan Bhanji; Dominique Biarent; Robert Bingham; Ashraf H Coovadia; Mary Fran Hazinski; Robert W Hickey; Vinay M Nadkarni; Amelia G Reis; Antonio Rodriguez-Nunez; James Tibballs; Arno L Zaritsky; David Zideman
Journal:  Pediatrics       Date:  2010-10-18       Impact factor: 7.124

3.  Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism.

Authors:  Erica M Richards; Gary Fiskum; Robert E Rosenthal; Irene Hopkins; Mary C McKenna
Journal:  Stroke       Date:  2007-04-05       Impact factor: 7.914

Review 4.  Resuscitating the Globally Ischemic Brain: TTM and Beyond.

Authors:  Melika Hosseini; Robert H Wilson; Christian Crouzet; Arya Amirhekmat; Kevin S Wei; Yama Akbari
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

5.  Association between hemoglobin levels and clinical outcomes in adult patients after in-hospital cardiac arrest: a retrospective cohort study.

Authors:  Chih-Hung Wang; Chien-Hua Huang; Wei-Tien Chang; Min-Shan Tsai; Ping-Hsun Yu; An-Yi Wang; Nai-Chuan Chen; Wen-Jone Chen
Journal:  Intern Emerg Med       Date:  2016-01-12       Impact factor: 3.397

6.  Normoxic resuscitation after cardiac arrest protects against hippocampal oxidative stress, metabolic dysfunction, and neuronal death.

Authors:  Viktoria Vereczki; Erica Martin; Robert E Rosenthal; Patrick R Hof; Gloria E Hoffman; Gary Fiskum
Journal:  J Cereb Blood Flow Metab       Date:  2006-06       Impact factor: 6.200

7.  Oximetry-guided reoxygenation improves neurological outcome after experimental cardiac arrest.

Authors:  Irina S Balan; Gary Fiskum; Julie Hazelton; Cynthia Cotto-Cumba; Robert E Rosenthal
Journal:  Stroke       Date:  2006-10-26       Impact factor: 7.914

Review 8.  Postischemic oxidative stress promotes mitochondrial metabolic failure in neurons and astrocytes.

Authors:  Gary Fiskum; Camelia A Danilov; Zara Mehrabian; Linda L Bambrick; Tibor Kristian; Mary C McKenna; Irene Hopkins; E M Richards; Robert E Rosenthal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Hyperoxic reperfusion after global cerebral ischemia promotes inflammation and long-term hippocampal neuronal death.

Authors:  Julie L Hazelton; Irina Balan; Greg I Elmer; Tibor Kristian; Robert E Rosenthal; Gary Krause; Thomas H Sanderson; Gary Fiskum
Journal:  J Neurotrauma       Date:  2010-04       Impact factor: 5.269

10.  Cardiac arrest in children.

Authors:  Erika E Tress; Patrick M Kochanek; Richard A Saladino; Mioara D Manole
Journal:  J Emerg Trauma Shock       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.